ED vs SPRO · P/E 18, rev $15.26B vs P/E 9.6, rev $48.0M
Consolidated Edison Inc (ED) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
ED currently screens at market cap $36.02B and trailing P/E 18.3. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the ED and SPRO stock pages for the full models.
Not investment advice.